750
S. E. Soliman, P. Kováč
PRACTICAL SYNTHETIC PROCEDURES
α-D-galactose (3) was purchased from Sigma-Aldrich.13 Solutions
in organic solvents were dried with anhydrous Na2SO4, and concen-
trated at 40 °C/2 kPa.
HRMS (ESI): m/z [M + Na]+ calcd for C20H29Cl3N4O11Na:
629.0791; found: 629.0791.
Anal. Calcd for C20H29Cl3N4O11: C, 39.52; H, 4.81; N, 9.22. Found:
C, 39.67; H, 4.88; N, 9.34.
Ethyl 4,6-O-Benzylidene-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-
D-galactopyranosyl)-1-thio-2-trichloroacetamido-β-D-glucopy-
ranoside (4)
8-Azido-3,6-dioxaoctyl 4,6-O-Benzylidene-2-deoxy-2-trichloro-
acetamido-β-D-glucopyranoside (8)
A solution of acetobromo-α-D-galactose13 (3; 307.5 mg, 0.75 mmol)
in anhydrous CH2Cl2 (1.5 mL) was added, at –30 °C in one portion,
to a mixture of glycosyl acceptor 27 (228.4 mg, 0.5 mmol), 1,1,3,3-
tetramethylurea (119.6 μL, 0.95 mmol), and powdered AgOTf
(218.4 mg, 0.85 mmol) in anhydrous CH2Cl2 (5 mL). The cooling
was removed and, with continued stirring, the mixture was allowed
to warm to r.t. (~1 h), when TLC (toluene–acetone, 8:1) indicated
that all acceptor had been consumed. Et3N (0.5 mL) was added, and
the mixture was diluted with CH2Cl2 (5 mL) and filtered through a
Celite® pad. The filtrate was washed successively with 0.5 M aq
HCl (20 mL), aq NaHCO3 (20 mL), and brine (20 mL), then dried.
After concentration, chromatography (toluene–acetone, 15:1) gave
the desired disaccharide 4; yield: 358 mg (91%).
Acetate 7 (11.37 g, 18.7 mmol) was treated with 1 M methanolic
NaOMe (3.0 mL) in MeOH (300 mL) overnight. The mixture was
neutralized with Amberlite IR-120, filtered, concentrated, and dried
in vacuo to give the expected intermediate triol, which was used
without further purification.
1H NMR (600 MHz, acetone-d6 + D2O): δ = 4.72 (d, J1,2 = 8.2 Hz,
1 H, H-1), 3.91–3.88 (m, 1 H, H-1′a), 3.84 (dd, J = 2.5, 11.8 Hz, 1
H, H-6b), 3.76–3.72 (m, 1 H, H-3), 3.70–3.57 (m, 11 H, H-1′b, H-2′,
H-3′, H-4′, H-5′, H-2, H-6a), 3.41–3.38 (m, 3 H, H-4, H-6′), 3.33–
3.30 (m, 1 H, H-5).
13C NMR (150 MHz, acetone-d6 + D2O): δ = 162.7 (NCOCCl3),
101.6 (C-1), 93.9 (CCl3), 77.4 (C-5), 74.6 (C-3), 72.1 (C-4), 71.1,
71.0, 70.9, 70.5 (4 CH2), 69.2 (C-1′), 62.4 (C-6), 58.6 (C-2), 51.2
(C-6′).
Mp 203.5–204.0 °C (i-PrOH).
[α]D –20 (c 1.0, CHCl3) [Lit.7 [α]D –28 (c 2.0, CH2Cl2)].
HRMS (ESI): m/z [M + NH4]+ calcd for C14H27Cl3N5O8: 498.0925;
found: 498.0932.
1H NMR (600 MHz, CDCl3): δ = 7.49–7.37 (m, 5 H, Ph), 7.01 (d,
J = 7.9 Hz, 1 H, NH), 5.56 (s, 1 H, PhCH), 5.32 (dd, J3,4 = 2.7 Hz,
J4,5 = 0.8 Hz, 1 H, H-4II), 5.19 (dd, J1,2 = 7.9 Hz, J2,3 = 10.4 Hz, 1 H,
H-2II), 5.10 (d, J1,2 = 10.4 Hz, 1 H, H-1I), 4.92 (dd, J2,3 = 10.4 Hz,
A solution of the foregoing triol in MeCN (150 mL) was treated
with benzaldehyde dimethyl acetal (5.1 mL, 33.7 mmol) and CSA
(82 mg) for 2 h at r.t. The reaction was quenched with Et3N
(5.0 mL) and concentrated. Chromatography (CHCl3–acetone, 9:1
→ 5:1) afforded 8; yield: 9.9 g (93% over two steps).
J
3,4 = 3.4 Hz, 1 H, H-3II), 4.76 (d, J1,2 = 7.9 Hz, 1 H, H-1II), 4.48 (t,
J = 9.5 Hz, 1 H, H-3I), 4.36 (dd, J = 4.9, 10.6 Hz, 1 H, H-6Ia), 4.11
(dd, J = 6.9, 11.3 Hz, 1 H, H-6II ), 4.01 (dd, J = 6.5, 11.3 Hz, 1 H,
H-6II ), 3.82–3.73 (m, 3 H, H-6Iba, H-4I, H-5II), 3.67 (m, 1 H, H-2I),
b
[α]D –35.6 (c 1.0, CHCl3).
3.57 (m, 1 H, H-5I), 2.74 (m, 2 H, SCH2), 2.12, 2.03, 1.95, 1.89 (4
1H NMR (600 MHz, CDCl3): δ = 7.50–7.36 (m, 5 H, Ph), 7.24 (d,
J = 7.2 Hz, 1 H, NH), 5.55 (s, 1 H, PhCH), 4.98 (d, J1,2 = 8.4 Hz, 1
H, H-1), 4.35 (dd, J = 4.9, 10.5 Hz, 1 H, H-6b), 4.24 (br ddd, J = 3.4,
9.1, 9.9 Hz, 1 H, H-3), 3.95–3.92 (m, 1 H, H-1′a), 3.84–3.78 (m, 2
H, H-6a, H-1′b), 3.72–3.61 (m, 9 H, H-2′, H-3′, H-4′, H-5′, H-2),
3.57 (t, J = 9.2 Hz, 1 H, H-4), 3.53–3.49 (m, 1 H, H-5), 3.41 (t,
J = 5.0 Hz, 2 H, H-6′), 3.09 (d, J = 3.4 Hz, 1 H, D2O exchange, OH).
13C NMR (150 MHz, CDCl3): δ = 162.7 (NCOCCl3), 136.9 (ipso
Ph), 129.3, 128.3, 126.1 (Ph), 101.9 (PhCH), 100.4 (C-1), 92.4
(CCl3), 81.5 (C-4), 70.8, 70.6 (2 CH2), 70.5 (C-3), 70.4, 70.0 (2
CH2), 68.7 (C-1′), 68.5 (C-6), 66.2 (C-5), 59.3 (C-2), 50.6 (C-6′).
s, 12 H, 4 COCH3), 1.28 (t, J = 7.4 Hz, 3 H, SCH2CH3).
13C NMR (150 MHz, CDCl3): δ = 170.3–169.6 (4 OCOCH3), 161.5
(NCOCCl3), 136.9 (ipso Ph), 129.3, 128.3, 126.1 (Ph), 101.3
(PhCH), 99.3 (C-1II), 92.3 (CCl3), 83.1 (C-1I), 78.7 (C-4I), 77.1 (C-
3I), 70.9 (C-3II), 70.7 (C-5I), 70.6 (C-5II), 68.8 (C-2II), 68.5 (C-6I),
66.8 (C-4II), 61.3 (C-6II), 57.5 (C-2I), 24.9 (SCH2), 20.7–20.5 (4
OCOCH3), 15.1 (SCH2CH3).
HRMS (ESI): m/z [M + Na]+ calcd for C31H38Cl3NO14NaS:
808.0971; found: 808.0971.
Anal. Calcd for C31H38Cl3NO14S: C, 47.31; H, 4.87; Cl, 13.51; N,
1.78; S, 4.07. Found: C, 47.23; H, 4.82; Cl, 13.66; N, 1.84; S, 3.88.
HRMS (ESI): m/z [M + NH4]+ calcd for C21H31Cl3N5O8: 586.1238;
found: 586.1241.
8-Azido-3,6-dioxaoctyl 3,4,6-Tri-O-acetyl-2-deoxy-2-trichloro-
acetamido-β-D-glucopyranoside (7)
Anal. Calcd for C21H27Cl3N4O8: C, 44.26; H, 4.78; N, 9.83. Found:
C, 44.26; H, 4.68; N, 9.75.
A mixture of thioglycoside 17 (5 g, 10.1 mmol), 8-azido-3,6-dioxa-
octan-1-ol5 (5; 2.5 g, 14.1 mmol), and 4-Å MS (2.5 g) in anhydrous
CH2Cl2 (40 mL) was stirred for 30 min under nitrogen. The mixture
was cooled to –20 °C and NIS (3.4 g, 15.2 mmol) followed by pow-
dered AgOTf (1.3 g, 5.1 mmol) were added with stirring. After 1 h,
the mixture was treated with Et3N (3.0 mL), filtered through
Celite®, and the filtrate was concentrated. Chromatography (tolu-
ene–acetone, 19:1 → 6:1) gave the spacer-equipped monosaccha-
ride 7; yield: 5.9 g (95%).
8-Azido-3,6-dioxaoctyl 4,6-O-Benzylidene-2-deoxy-3-O-
(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-2-trichloroacet-
amido-β-D-glucopyranoside (6)
Pathway 1
A mixture of thioglycoside disaccharide 4 (787 mg, 1.0 mmol), 8-
azido-3,6-dioxaoctan-1-ol5 (5; 262 mg, 1.5 mmol), and 4-Å MS (0.5
g) in anhydrous CH2Cl2 (10 mL) was stirred for 30 min under nitro-
gen. The mixture was cooled to –15 °C and NIS (337 mg, 1.5 mmol)
followed by powdered AgOTf (128 mg, 0.5 mmol) were added with
stirring. After 1 h, the mixture was treated with Et3N (1.0 mL), fil-
tered through Celite®, and the filtrate was concentrated. Chroma-
tography (hexane–acetone, 2:1) gave the spacer-equipped
disaccharide 6; yield: 751 mg (83%).
[α]D –11.9 (c 1.0, CHCl3).
1H NMR (600 MHz, CDCl3): δ = 7.01 (d, J = 8.9 Hz, 1 H, NH), 5.29
(dd, J = 9.3, 10.6 Hz, 1 H, H-3), 5.12 (t, J = 9.6 Hz, 1 H, H-4), 4.91
(d, J1,2 = 8.5 Hz, 1 H, H-1), 4.29 (dd, J = 4.7, 12.3 Hz, 1 H, H-6b),
4.16 (dd, J = 2.4, 12.3 Hz, 1 H, H-6a), 4.03 (dt, J1,2 = J2,NH ~8.5 Hz,
J2,3 = 10.6 Hz, 1 H, H-2), 3.91–3.84 (m, 2 H, H-1′), 3.78–3.62 (m, 9
Mp 124.0–124.5 °C (i-PrOH).
[α]D –15.1 (c 1.8, CHCl3).
H, H-2′, H-3′, H-4′, H-5′, H-5), 3.48 (t, J = 5.0 Hz, 2 H, H-6′), 2.10,
2.03, 2.02 (3 s, 9 H, 3 COCH3).
13C NMR (150 MHz, CDCl3): δ = 170.7–169.4 (3 OCOCH3), 162.0
(NCOCCl3), 100.9 (C-1), 92.4 (CCl3), 72.2 (C-3), 72.0 (C-5), 71.2
(CH2), 70.6, 70.3, 69.9 (3 CH2), 68.4 (C-4), 68.3 (C-1′), 62.1 (C-6),
56.0 (C-2), 50.6 (C-6′), 20.8, 20.6, 20.5 (3 OCOCH3).
1H NMR (600 MHz, CDCl3): δ = 7.50–7.37 (m, 5 H, Ph), 7.10 (d,
J = 7.5 Hz, 1 H, NH), 5.55 (s, 1 H, PhCH), 5.31 (dd, J3,4 = 3.4 Hz,
J
4,5 = 0.6 Hz, 1 H, H-4II), 5.19 (dd, J1,2 = 8.0 Hz, J2,3 = 10.4 Hz, 1 H,
H-2II), 5.12 (d, J1,2 = 8.3 Hz, 1 H, H-1I), 4.91 (dd, J2,3 = 10.4 Hz,
Synthesis 2014, 46, 748–751
© Georg Thieme Verlag Stuttgart · New York